Literature DB >> 10336918

Comparing two different protocols for tilt table testing: sublingual glyceryl trinitrate versus isoprenaline infusion.

S Oraii1, M Maleki, M Minooii, P Kafaii.   

Abstract

OBJECTIVE: To assess the diagnostic value and safety of sublingual glyceryl trinitrate tilt testing compared with isoprenaline infusion in patients with unexplained syncope.
DESIGN: Glyceryl trinitrate and isoprenaline tilt tests were performed in two successive days on a random basis in cases and controls.
SETTING: Outpatient cases with syncope referred to Shahid Rajaii Heart Hospital.
SUBJECTS: 65 consecutive patients with unexplained syncope after thorough work up; 20 healthy volunteers.
RESULTS: Positive responses were observed in 20 patients during the passive phase. Of the other 45 patients, positive responses occurred in 25 cases during the glyceryl trinitrate phase and in 26 cases during the isoprenaline phase. In the control group, positive responses during the passive, glyceryl trinitrate, and isoprenaline phases occurred in one, one, and two cases, respectively. The sensitivity and specificity of the protocols were 55% and 94.7%, respectively, for glyceryl trinitrate v 58% and 89.4% for isoprenaline. Owing to discordant responses in 75% of the cases, the sequential use of the tests (if one was negative) would increase the sensitivity to 84% while decreasing the specificity slightly (to 84%). Side effects were less frequent with glyceryl trinitrate.
CONCLUSIONS: Sublingual glyceryl trinitrate tilt testing is an effective and safe alternative to the isoprenaline infusion test and can be used as a complementary test.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336918      PMCID: PMC1729063          DOI: 10.1136/hrt.81.6.603

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Discrepancy between head-up tilt test results utilizing different protocols in the same patient.

Authors:  D L Janosik; H Genovely; C Fredman; P Bjerregaard
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

2.  Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope.

Authors:  H Calkins; A Kadish; J Sousa; S Rosenheck; F Morady
Journal:  Am J Cardiol       Date:  1991-01-15       Impact factor: 2.778

3.  Prospective evaluation of high-dose or low-dose isoproterenol upright tilt protocol for unexplained syncope in young adults.

Authors:  R Carlioz; P Graux; J Haye; T Letourneau; Y Guyomar; E Hubert; J C Bodart; B Lequeuche; J P Burlaton
Journal:  Am Heart J       Date:  1997-03       Impact factor: 4.749

4.  Head-up tilt: a useful test for investigating unexplained syncope.

Authors:  R A Kenny; A Ingram; J Bayliss; R Sutton
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

5.  Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin.

Authors:  B P Grubb; P Temesy-Armos; H Hahn; L Elliott
Journal:  Am J Med       Date:  1991-01       Impact factor: 4.965

6.  Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing.

Authors:  J S Sra; A J Anderson; S H Sheikh; B Avitall; P J Tchou; P J Troup; C J Gilbert; M Akhtar; M R Jazayeri
Journal:  Ann Intern Med       Date:  1991-06-15       Impact factor: 25.391

7.  Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope.

Authors:  G Pongiglione; F A Fish; J F Strasburger; D W Benson
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

8.  Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope.

Authors:  A Raviele; G Gasparini; F Di Pede; C Menozzi; M Brignole; M Dinelli; P Alboni; E Piccolo
Journal:  Am Heart J       Date:  1994-01       Impact factor: 4.749

9.  Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects.

Authors:  M Brignole; C Menozzi; L Gianfranchi; D Oddone; G Lolli; A Bertulla
Journal:  Am Heart J       Date:  1991-12       Impact factor: 4.749

10.  Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing.

Authors:  K G Lurie; J Dutton; R Mangat; D Newman; S Eisenberg; M Scheinman
Journal:  Am J Cardiol       Date:  1993-12-01       Impact factor: 2.778

View more
  7 in total

1.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

2.  Sub-Lingual Spray Versus Pearl of TNG as A Provocative Agent for Tilt Table Test.

Authors:  Reza Karbasi-Afshar; Amin Saburi; Ayat Shahmari; Arezoo Khosravi
Journal:  J Clin Diagn Res       Date:  2013-10-05

Review 3.  Head Up Tilt Testing: An Appraisal of Its Current Role in the Management of Patients with Syncope.

Authors:  Paula Macedo; Luiz Roberto Leite; Samuel J Asirvatham; Denise Tessariol Hachul; Leopoldo Luiz Dos Santos-Neto; Win-Kuang Shen
Journal:  J Atr Fibrillation       Date:  2011-07-15

4.  Does the use of a syncope diagnostic protocol improve the investigation and management of syncope?

Authors:  D J Farwell; A N Sulke
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

5.  Transient aphasia: a rare complication of head-up tilt test.

Authors:  Weihong Chu; Cheng Wang; Ping Lin; Fang Li; Lijia Wu; Zhenwu Xie
Journal:  Neurol Sci       Date:  2014-02-11       Impact factor: 3.307

6.  Clinical Features of Patients Undergoing the Head-Up Tilt Test and Its Safety and Efficacy in Diagnosing Vasovagal Syncope in 4,873 Patients.

Authors:  Lingping Xu; Xiangqi Cao; Rui Wang; Yichao Duan; Ye Yang; Junlong Hou; Jing Wang; Bin Chen; Xianjun Xue; Bo Zhang; Hua Ma; Chaofeng Sun; Fengwei Guo
Journal:  Front Cardiovasc Med       Date:  2022-01-12

7.  The type of the functional cardiovascular response to upright posture is associated with arterial stiffness: a cross-sectional study in 470 volunteers.

Authors:  Anna M Tahvanainen; Antti J Tikkakoski; Jenni K Koskela; Klaus Nordhausen; Jani M Viitala; Miia H Leskinen; Mika A P Kähönen; Tiit Kööbi; Marko T Uitto; Jari Viik; Jukka T Mustonen; Ilkka H Pörsti
Journal:  BMC Cardiovasc Disord       Date:  2016-05-23       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.